Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
- PMID: 35507492
- DOI: 10.1056/NEJMc2202778
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
Comment in
-
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. Reply.N Engl J Med. 2022 May 5;386(18):1768. doi: 10.1056/NEJMc2202778. N Engl J Med. 2022. PMID: 35507493 No abstract available.
Comment on
-
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical